Abstract
A novel series of 2-aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides have been identified as potent antivirals against human herpesviruses. These compounds demonstrate broad-spectrum inhibition of the herpesvirus polymerases HCMV, HSV-1, EBV, and VZV with high specificity compared to human DNA polymerases.
MeSH terms
-
Antiviral Agents / chemical synthesis
-
Antiviral Agents / pharmacology*
-
Antiviral Agents / therapeutic use
-
Binding, Competitive
-
Cytomegalovirus / drug effects*
-
DNA-Directed DNA Polymerase
-
Enzyme Inhibitors / chemical synthesis
-
Enzyme Inhibitors / pharmacology*
-
Enzyme Inhibitors / therapeutic use
-
Ethylamines / chemical synthesis
-
Ethylamines / pharmacology*
-
Exodeoxyribonucleases / antagonists & inhibitors*
-
Herpes Zoster / drug therapy
-
Herpesviridae / drug effects*
-
Herpesviridae / enzymology
-
Herpesvirus 1, Human / drug effects*
-
Herpesvirus 4, Human / drug effects*
-
Humans
-
Models, Chemical
-
Nucleic Acid Synthesis Inhibitors*
-
Pyridines / chemical synthesis
-
Pyridines / pharmacology*
-
Structure-Activity Relationship
-
Viral Proteins / antagonists & inhibitors*
Substances
-
Antiviral Agents
-
Enzyme Inhibitors
-
Ethylamines
-
Nucleic Acid Synthesis Inhibitors
-
Pyridines
-
Viral Proteins
-
DNA-Directed DNA Polymerase
-
Exodeoxyribonucleases
-
DNA polymerase, Simplexvirus